Evidence map›Paper›PMID 26291613›Full record

ArticlePLoS pathogens2015

Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid Interface.

Kevin R McCarthy, Andrea Kirmaier, Patrick Autissier, Welkin E Johnson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Onward transmission of viruses: how do viruses emerge to cause epidemics after spillover?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  14. Article
  15. CD4 receptor diversity in chimpanzees protects against SIV infection.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Evolutionary journey of the retroviral restriction geneProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin R McCarthyHarvard Program in Virology, Harvard Medical School, Boston, Massachusetts, United States of America; Biology Department, Boston College, Chestnut Hill, Massachusetts, United States of America.
Andrea KirmaierBiology Department, Boston College, Chestnut Hill, Massachusetts, United States of America.
Patrick AutissierBiology Department, Boston College, Chestnut Hill, Massachusetts, United States of America.
Welkin E JohnsonBiology Department, Boston College, Chestnut Hill, Massachusetts, United States of America.
Boston College · US

Funding

Cross-Species transmission and adaptation of primate lentivirusesR01AI083118 · NIAID · HARVARD MEDICAL SCHOOL · PI JOHNSON, WELKIN E · 2009 to 2019
$4.0M
Intrinsic Immunity and AIDSR01AI095092 · NIAID · HARVARD MEDICAL SCHOOL · PI JOHNSON, WELKIN E · 2011 to 2015
$3.0M
NIAID NIH HHS AI083118NIAID NIH HHS AI095092NIAID NIH HHS R01 AI083118NIAID NIH HHS R01 AI095092
6 · The paper itself

Abstract

The widespread distribution of lentiviruses among African primates, and the lack of severe pathogenesis in many of these natural reservoirs, are taken as evidence for long-term co-evolution between the simian immunodeficiency viruses (SIVs) and their primate hosts. Evidence for positive selection acting on antiviral restriction factors is consistent with virus-host interactions spanning millions of years of primate evolution. However, many restriction mechanisms are not virus-specific, and selection cannot be unambiguously attributed to any one type of virus. We hypothesized that the restriction factor TRIM5, because of its unique specificity for retrovirus capsids, should accumulate adaptive changes in a virus-specific fashion, and therefore, that phylogenetic reconstruction of TRIM5 evolution in African primates should reveal selection by lentiviruses closely related to modern SIVs. We analyzed complete TRIM5 coding sequences of 22 Old World primates and identified a tightly-spaced cluster of branch-specific adaptions appearing in the Cercopithecinae lineage after divergence from the Colobinae around 16 million years ago. Functional assays of both extant TRIM5 orthologs and reconstructed ancestral TRIM5 proteins revealed that this cluster of adaptations in TRIM5 specifically resulted in the ability to restrict Cercopithecine lentiviruses, but had no effect (positive or negative) on restriction of other retroviruses, including lentiviruses of non-Cercopithecine primates. The correlation between lineage-specific adaptations and ability to restrict viruses endemic to the same hosts supports the hypothesis that lentiviruses closely related to modern SIVs were present in Africa and infecting the ancestors of Cercopithecine primates as far back as 16 million years ago, and provides insight into the evolution of TRIM5 specificity.

Indexed as

Evolution, MolecularLentiviruses, PrimateAmino Acid SequenceAnimalsBlotting, WesternCarrier ProteinsCercopithecidaeLentivirusLentivirus InfectionsMolecular Sequence DataMonkey DiseasesPhylogenyReverse Transcriptase Polymerase Chain ReactionCarrier Proteins

Identifiers

PMID26291613
PMCPMC4546234
OpenAlexW2110943988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.